Predictive Oncology Inc   (POAI)
Other Ticker:  
Price: $3.4200 $-0.09 -2.564%
Day's High: $3.6 Week Perf: 5.23 %
Day's Low: $ 3.40 30 Day Perf: 6.54 %
Volume (M): 16 52 Wk High: $ 7.12
Volume (M$): $ 56 52 Wk Avg: $3.16
Open: $3.60 52 Wk Low: $0.19

 Market Capitalization (Millions $) 14
 Shares Outstanding (Millions) 4
 Employees -
 Revenues (TTM) (Millions $) 2
 Net Income (TTM) (Millions $) -18
 Cash Flow (TTM) (Millions $) -13
 Capital Exp. (TTM) (Millions $) 0

Predictive Oncology Inc
Predictive Oncology Inc is a company that focuses on using artificial intelligence (AI) and data analytics to provide personalized treatment options for cancer patients. They analyze large amounts of genomic and clinical data to develop models that help in predicting the most effective treatment methods for different types of cancer. Their aim is to improve patient outcomes by delivering targeted therapies that are tailored to individual patients based on the specific genetic mutations present in their tumors.

   Company Address: 91 43rd Street, Suite 110 Pittsburgh 15201 PA
   Company Phone Number: 432-1500   Stock Exchange / Ticker: NASDAQ POAI
   POAI is expected to report next financial results on March 20, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Predictive Oncology Inc

Predictive Oncology Inc Achieves Staggering 56.87% Surge in Revenue During Third Quarter of 2023, Holding Promise for Cancer Treatment Breakthroughs

Predictive Oncology Inc, a medical equipment and supplies company, has experienced a troubling third quarter of 2023, with extended losses per share and a significant increase in revenue. However, despite these positive revenue figures, the company's net shortfall still shows cause for concern. Additionally, the stock's recent decline and market performance suggest a potential bleak future for Predictive Oncology Inc.
Financial Performance and Losses
In the third quarter of 2023, Predictive Oncology Inc faced losses that extended to $0.78 per share, a drastic increase compared to $0.05 per share in the same quarter the year before. Although the company experienced an improvement in earnings per share (EPS) from the previous quarter, it is important to note that EPS still stood at a concerning $0.98 per share. These figures indicate a persistent and significant loss for the company.

Predictive Oncology Inc

Predictive Oncology Inc. Reports Impressive Revenue Surge but Faces Rising Losses per Share in Recent Financial Results

Predictive Oncology Inc, a medical equipment and supplies company, recently released its financial results for the most recent fiscal period ending June 30, 2023. While the company witnessed a significant increase in revenue, the losses per share have also risen. This article will analyze the financial results and put them into context.
Financial Results:
In the most recent fiscal period, Predictive Oncology Inc experienced a loss per share of $-0.98, a substantial increase from the previous year's loss of $-0.86 per share. Despite this, the company's revenue surged by 31.895%, reaching $0.49 million compared to the prior fiscal period's revenue of $0.24 million.

Predictive Oncology Inc

Pandemic Disruptions and Economic Slowdown: Predictive Oncology Inc Battles the Odds and Aims for Long-Term Triumph in the Cutthroat Bio-Tech and Pharma Sector

Despite facing challenges in the most recent fiscal period, Predictive Oncology Inc is poised for long-term success in the competitive biotechnology and pharmaceuticals industry. While the company's net deficit per share rose in the most recent quarter, it is important to focus on the bigger picture and look at the factors contributing to this decline.
Firstly, the decrease in revenue can be attributed to external factors such as the ongoing pandemic and economic slowdown, which have impacted many businesses across various industries. This is not an indication of the company's performance or potential.


Predictive Oncology Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com